NoGeneST™ Anti-DRD2 Aptamer, aDRD2 aptamer

Name: NoGeneST™ Anti-DRD2 Aptamer, aDRD2 aptamer
SKU: NRYF-0625-HZ121
Rating: 5 (1 reviews)

[CAT#: NRYF-0625-HZ121]

Aptamer designed to specifically recognize the D2 Dopamine Receptor, a primary target for antipsychotic medications.

Target:: DRD2

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

Product Overview

Relevant Diseases

Depression

Properties

Size

5 nmol. 10 nmol. 50 nmol

Soluble In

PBS; buffer system with Serum; other

Purity

>90%

Shipping

Room temperature

Storage

Powder Form: Stable for 3 years when stored at -20°C.
In Solvent: Stable for 6 months when aliquoted and stored at -80°C

Research Use Only

For Research Use Only

Target Details

Target

DRD2

Full Name

D(2) Dopamine Receptor

Gene ID

1813

Uniprot ID

P14416

Target Overview

The D2 dopamine receptor (DRD2) is a G protein-coupled receptor (GPCR) and one of the principal receptors for the neurotransmitter dopamine. It is highly expressed in the brain in pathways that are crucial for motor control, motivation, reward, and cognition. DRD2 plays a central role in neuropsychiatry as it is the primary pharmacological target for all typical and atypical antipsychotic drugs, which are used to treat schizophrenia and other psychotic disorders. The receptor is also critically implicated in the pathophysiology of Parkinson's disease and addiction.

Publications